Birkenstock (NYSE:BIRK) Earns “Outperform” Rating from Telsey Advisory Group

Birkenstock (NYSE:BIRK)‘s stock had its “outperform” rating reissued by Telsey Advisory Group in a report issued on Thursday,Benzinga reports. They currently have a $70.00 price target on the stock. Telsey Advisory Group’s target price suggests a potential upside of 27.41% from the company’s current price.

A number of other analysts have also recently weighed in on BIRK. Deutsche Bank Aktiengesellschaft raised their price objective on Birkenstock from $65.00 to $66.00 and gave the stock a “buy” rating in a research report on Thursday, December 19th. UBS Group raised their price objective on Birkenstock from $83.00 to $95.00 and gave the stock a “buy” rating in a research report on Thursday, December 19th. BMO Capital Markets raised their price objective on Birkenstock from $60.00 to $70.00 and gave the stock an “outperform” rating in a research report on Thursday, December 19th. Robert W. Baird raised their price objective on Birkenstock from $65.00 to $72.00 and gave the stock an “outperform” rating in a research report on Thursday, December 19th. Finally, Piper Sandler assumed coverage on Birkenstock in a research report on Tuesday, December 10th. They set an “overweight” rating and a $65.00 price target for the company. Two research analysts have rated the stock with a hold rating, fourteen have issued a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $68.31.

Birkenstock Stock Down 0.1 %

Shares of NYSE BIRK opened at $54.94 on Thursday. The company has a current ratio of 2.60, a quick ratio of 1.20 and a debt-to-equity ratio of 0.50. The stock has a market capitalization of $10.32 billion, a PE ratio of 50.87, a price-to-earnings-growth ratio of 1.10 and a beta of 1.61. The stock’s fifty day simple moving average is $57.59 and its two-hundred day simple moving average is $53.26. Birkenstock has a 12-month low of $41.00 and a 12-month high of $64.78.

Birkenstock (NYSE:BIRK) last announced its earnings results on Thursday, February 20th. The company reported $0.19 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.16 by $0.03. Birkenstock had a return on equity of 8.82% and a net margin of 10.57%. As a group, analysts expect that Birkenstock will post 1.77 EPS for the current fiscal year.

Hedge Funds Weigh In On Birkenstock

Several institutional investors and hedge funds have recently modified their holdings of the stock. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its holdings in shares of Birkenstock by 170.3% in the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 72,538 shares of the company’s stock valued at $4,110,000 after buying an additional 45,700 shares during the period. Woodline Partners LP increased its stake in shares of Birkenstock by 129.7% in the 4th quarter. Woodline Partners LP now owns 191,219 shares of the company’s stock valued at $10,834,000 after purchasing an additional 107,981 shares in the last quarter. Tairen Capital Ltd purchased a new position in shares of Birkenstock in the 4th quarter valued at about $1,133,000. ThornTree Capital Partners LP purchased a new position in shares of Birkenstock in the 4th quarter valued at about $19,506,000. Finally, Shellback Capital LP increased its stake in shares of Birkenstock by 26.1% in the 4th quarter. Shellback Capital LP now owns 120,700 shares of the company’s stock valued at $6,839,000 after purchasing an additional 25,000 shares in the last quarter. Institutional investors and hedge funds own 19.93% of the company’s stock.

About Birkenstock

Birkenstock Holding plc manufactures and sells footwear products. It also offers sandals, shoes, closed-toe silhouettes, skincare products, and accessories. The company sells its products through e-commerce sites and a network of owned retail stores, as well as business-to-business channels. It operates in the United States, Brazil, Canada, Mexico, Europe, APMA, and internationally.